Gene therapy for sickle cell disease passes key preclinical test

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.

Gene therapy to boost fetal hemoglobin continues to do well in sickle cell trial

Could deer hold clues about the link between malaria resistance and sickle cell?

HemaApp screens for anemia, blood conditions without needle sticks

Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette

Sickle cell gene therapy passes key preclinical test - Boston Children's Answers

The daily dilemmas of a student with sickle cell anaemia, Students

gene therapy Archives - Page 4 of 5 - Boston Children's Answers

Computer models provide new understanding of sickle cell disease

HemaApp screens for anemia, blood conditions without needle sticks

Milwaukee Area Sickle Cell Support Group